CD59 and benign prostatic hyperplasia: The increased levels of the HexNAc(5)Hex(6)Fuc(1)NeuAc(3) N-glycopeptide from PTGDS and decreased levels of the HexNAc(3)Hex(1)Fuc(1) O-glycopeptide from CD59 in PCa compared to BPH urine was confirmed (Supplementary Figure 5).